Can new rules in Ohio address a pharmacy staffing shortage and improve care?
UC pharmacy expert joins WVXU's Cincinnati Edition
As pharmacies face a staffing shortage nationwide, pharmacy workers are often being asked to do more with less. The Ohio Board of Pharmacy has released new rules to help address the issue.
The rules, effective May 1, include minimum staffing levels based on all services offered rather than only on how many prescriptions are filled and a requirement to create a process where workers can report concerns to management that are addressed in a timely manner.
The University of Cincinnati's Michael Hegener, PharmD, joined WVXU's Cincinnati Edition to discuss the new rules and the underlying issues currently affecting pharmacies. He said many of the issues are caused by tighter profit margins, as pharmacy benefit managers are sometimes reimbursing pharmacies less than what they have to pay for the drugs.
"You can actually lose money filling a prescription," said Hegener, director of the Wuest Family Pharmacy Practice Skills Center and associate professor of pharmacy in UC's James L. Winkle College of Pharmacy. "So how can you pay to have an adequate staffing model when you have to try to, again, do more with less?"
Hegener said the new rules are a "step in the right direction" if pharmacies implement them as intended without finding loopholes.
"I do think its a positive step and helps hopefully mitigate some of these concerns that pharmacists have had," he said.
Listen to the Cincinnati Edition segment.
Featured photo at top of a pharmacist speaking with a customer. Photo/Drazen Zigic/iStock.
Related Stories
Local 12: Pharmacies adjusting hours due to staffing issues
April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.
WVXU: Exploring the under-regulated dietary supplements industry
August 17, 2022
The University of Cincinnati's Michael Hegener, PharmD, was a panelist on WVXU's Cincinnati Edition discussing the under-regulated dietary supplements industry.
Drug Discovery News: Silence in healthy cells makes FOXR2 a potential cancer target
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.